Comparing the efficacy of prulifloxacin against cefixime as a preventive treatment before transrectal ultrasound guided prostate biopsy.

Phase 4

• Conditions: Prostate cancer suspicious; Urinary tract infection; Renal and Urogenital - Other renal and urogenital disorders; Cancer - Prostate

• Registration Number: ACTRN12616001344482
• Lead Sponsor: niversity of Thessaly

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-09-26
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: Male
• Target Recruitment: 200

Inclusion Criteria

Patients eligible for prostate biopsy

Exclusion Criteria

Prulifloxacin or cefixime allergy

Kidney failure,

Known resistance to prulifloxacin or cefixime

Study & Design

• Study Type: Interventional
• Study Design: Not specified